Misty
Lv71
4758 积分
2022-04-24 加入
-
A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors
23天前
已完结
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
30天前
已完结
-
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
30天前
已完结
-
抗体药物偶联物在三阴性乳腺癌中的应用
2个月前
已完结
-
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancer
2个月前
已完结
-
中国晚期三阴性乳腺癌临床诊疗指南(2024版)
3个月前
已完结
-
Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan
4个月前
已完结
-
Basal cell carcinomas in a tertiary referral centre: a systematic analysis
5个月前
已完结
-
The current clinical approach to difficult-to-treat basal cell carcinomas
5个月前
已完结
-
Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment
5个月前
已完结